Health and Healthcare
National Employee Morale Day At XenoPort (XNPT)
Published:
Last Updated:
Biotech firm XenoPort (XNPT) will lay-off half of its employees. The company lists 219 full-time workers.
On February 17, the FDA rejected a restless leg syndrome drug being developed by XenoPort and GlaxoSmithKline (GSK) because of a potential link to cancer found in rats. Six research firms downgraded the stock including DeutscheBank and Citigroup. XenoPort’s stock dropped from $20 to under $7 in a day.
To make shareholders feel better Ronald W. Barrett, Ph.D., XenoPort’s chief executive officer said, “We are fortunate to have a number of product candidates in clinical development as well as several other advanced preclinical compounds that can be developed.” But, there is apparently not enough potential in the candidates to keep the staff intact.
Dr. Barrett made $1.9 million last year, according to the company’s proxy. He had to fire a lot of people to cover that.
Douglas A. McIntyre
The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.
But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.